Zervos John C & Pappas Ellini T Dpm Wakefield, RI - 02879

Zervos John C & Pappas Ellini T Dpm is categorized under Podiatrists in Wakefield, RI and active since 1993.

Zervos John C & Pappas Ellini T Dpm was established in 1993, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Podiatrists business, which does work in the B2C market, and is classified as a Podiatrists, under code number 621391 by the NAICS.

If you are seeking more information, feel free to contact John C Zervos at the company’s single location by writing to 70 Kenyon Avenue Unit 212, Wakefield, Rhode Island RI 02879 or by phoning (401) 789-8912. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Zervos John C & Pappas Ellini T Dpm
Contact Person: John C Zervos
Address: 70 Kenyon Avenue Unit 212, Wakefield, Rhode Island 02879
Phone Number: (401) 789-8912
Annual Revenue (USD): $100.000 to $499.999
Founded: 1993
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Podiatrists
SIC Code: 8043
NAICS Code: 621391
Share This Business:

Zervos John C & Pappas Ellini T Dpm was started in 1993 to provide professional Podiatrists under the SIC code 8043 and NAICS code 621391. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact John C Zervos for inquiries that concern Zervos John C & Pappas Ellini T Dpm by calling the company number (401) 789-8912, as your correspondence is most welcome. Additionally, the physical location of the single location of Zervos John C & Pappas Ellini T Dpm can be found at the coordinates 41.431369,-71.495307 as well as the street address 70 Kenyon Avenue Unit 212 in Wakefield, Rhode Island 02879.

For its online presence, you may visit Zervos John C & Pappas Ellini T Dpm’s website at and engage with its social media outlets through on Twitter and on Facebook.